Atlas Trials

A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab

Clinical trial NCT03804554 · COMPLETED

Trial details

NCT number
NCT03804554
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Study type
OBSERVATIONAL
Non-Small Cell Lung Cancer
Start date
2018-10-03
Primary completion
2021-08-12
Enrollment
503

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.